Status:
COMPLETED
Association Between CGM Metrics in Type 2 Diabetes Pregnancy and Perinatal Morbidity
Lead Sponsor:
Centre Hospitalier Sud Francilien
Conditions:
Type 2 Diabetes Mellitus (T2DM)
Pregnancy
Eligibility:
FEMALE
18+ years
Brief Summary
The purpose of this observational study is to measure the association between continuous glucose monitoring (CGM) parameters and perinatal morbidity in offspring of women with type 2 diabetes. Specifi...
Detailed Description
Continuous glucose monitoring (CGM) data in pregnant women living with type 2 diabetes (T2D) and its association with perinatal morbidity are very recent and remain scarce. Moreover, perinatal morbidi...
Eligibility Criteria
Inclusion
- Adult patient
- Patient diagnosed with type 2 diabetes before or during pregnancy (fasting blood glucose \> 126 mg/dL, blood glucose \> 200 mg/dL after an oral glucose tolerance test, or HbA1c \> 6.5%)
- Patient who has undergone continuous glucose monitoring at least once during pregnancy
Exclusion
- Multiple pregnancy
- Pregnancy terminated before 20 weeks of amenorrhea
- Delivery outside CHSF
- Patient and/or legal guardians of the newborn who objected to the use of data
Key Trial Info
Start Date :
May 15 2025
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 26 2025
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06892314
Start Date
May 15 2025
End Date
November 26 2025
Last Update
December 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Sud Francilien
Corbeil-Essonnes, France, France, 91110